Vitreoretinopathy, Proliferative

"Vitreoretinopathy, Proliferative" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Vitreoretinal membrane shrinkage or contraction secondary to the proliferation of primarily retinal pigment epithelial cells and glial cells, particularly fibrous astrocytes, followed by membrane formation. The formation of fibrillar collagen and cellular proliferation appear to be the basis for the contractile properties of the epiretinal and vitreous membranes.

Descriptor ID	D018630
MeSH Number(s)	C11.768.890
Concept/Terms	Vitreoretinopathy, Proliferative Vitreoretinopathy, Proliferative Proliferative Vitreoretinopathies Vitreoretinopathies, Proliferative Vitreoretinopathy Neovascular Inflammatory Inflammatories, Vitreoretinopathy Neovascular Inflammatory, Vitreoretinopathy Neovascular Neovascular Inflammatories, Vitreoretinopathy Neovascular Inflammatory, Vitreoretinopathy Vitreoretinopathy Neovascular Inflammatories Proliferative Vitreoretinopathy

Below are MeSH descriptors whose meaning is more general than "Vitreoretinopathy, Proliferative".

Diseases [C]
Eye Diseases [C11]
Retinal Diseases [C11.768]
Vitreoretinopathy, Proliferative [C11.768.890]

Below are MeSH descriptors whose meaning is related to "Vitreoretinopathy, Proliferative".

Below are MeSH descriptors whose meaning is more specific than "Vitreoretinopathy, Proliferative".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Vitreoretinopathy, Proliferative" by people in this website by year, and whether "Vitreoretinopathy, Proliferative" was a major or minor topic of these publications.

Bar chart showing 40 publications over 17 distinct years, with a maximum of 6 publications in 2023

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1996	1	0	1
2002	1	0	1
2005	1	0	1
2007	1	1	2
2008	0	1	1
2012	0	1	1
2014	1	1	2
2015	2	1	3
2016	0	1	1
2017	1	1	2
2018	2	0	2
2019	4	0	4
2020	3	1	4
2021	2	0	2
2022	5	0	5
2023	6	0	6
2024	2	0	2

Below are the most recent publications written about "Vitreoretinopathy, Proliferative" by people in Profiles.

Mammo DA, Wai K, Rahimy E, Pan CK, Srivastava SK, Mruthyunjaya P. Association of Cutaneous Keloids, Hypertrophic Scarring, and Fibrosis with Risk of Postoperative Proliferative Vitreoretinopathy. Ophthalmology. 2024 Aug; 131(8):961-966.

View in: PubMed
Shahlaee A, Yang D, Chen J, Lamy R, Stewart JM. Vitreous Biomarkers for Proliferative Vitreoretinopathy Prognostication in Patients Undergoing Primary Retinal Detachment Repair. Transl Vis Sci Technol. 2024 01 02; 13(1):3.

View in: PubMed
Sinha AK, Durrani AF, Li KX, Zhou Y, Musch DC, Zacks DN, Huvard MJ. Retinal Detachments after Open-Globe Injury: Risk Factors and Outcomes. Ophthalmol Retina. 2024 Apr; 8(4):340-349.

View in: PubMed
Salabati M, Massenzio E, Kim J, Awh K, Anderson H, Mahmoudzadeh R, Wakabayashi T, Hsu J, Garg S, Ho AC, Khan MA. Primary Retinal Detachment Repair in Eyes Deemed High Risk for Proliferative Vitreoretinopathy: Surgical Outcomes in 389 Eyes. Ophthalmol Retina. 2023 11; 7(11):954-958.

View in: PubMed
Marshall AJ, Barnwell EL, Greven MA. Bilateral Proliferative Retinopathy as the Initial Presentation of Atypical Hemolytic Uremic Syndrome: A Case Report. Ophthalmic Surg Lasers Imaging Retina. 2023 05; 54(5):297-300.

View in: PubMed
Salabati M, Lee J, Patel SN, Hamburger J, Rama M, Gupta A, Mahmoudzadeh R, Xu D, Kuriyan AE, Khan MA. Risk factors for surgical failure after primary scleral buckling for rhegmatogenous retinal detachment. Can J Ophthalmol. 2024 04; 59(2):e155-e160.

View in: PubMed
Crispin M, Gerhart J, Heffer A, Martin M, Abdalla F, Bravo-Nuevo A, Philp NJ, Kuriyan AE, George-Weinstein M. Myo/Nog Cells Give Rise to Myofibroblasts During Epiretinal Membrane Formation in a Mouse Model of Proliferative Vitreoretinopathy. Invest Ophthalmol Vis Sci. 2023 02 01; 64(2):1.

View in: PubMed
Mundae R, Haq Z, Adams OE, Parke DW, Tang PH. Evolving Trends for the Clinical Presentation of Primary Rhegmatogenous Retinal Detachments From Early to Late Phases of the COVID-19 Pandemic. Ophthalmic Surg Lasers Imaging Retina. 2023 02; 54(2):78-83.

View in: PubMed
Starr MR, Huang D, Wong JC, Patel LG, Ammar M, Hsu J, Sivalingam A, Mehta S, Ho AC, Kuriyan AE, Khan MA, Cohen MN, Xu D, Lee D, Moster MR, Yonekawa Y. PREVALENCE, CHARACTERISTICS, AND OUTCOMES OF RHEGMATOGENOUS RETINAL DETACHMENT IN EYES WITH TRABECULECTOMY OR GLAUCOMA DRAINAGE DEVICES. Retina. 2022 11 01; 42(11):2039-2045.

View in: PubMed
Wang V, Heffer A, Roztocil E, Feldon SE, Libby RT, Woeller CF, Kuriyan AE. TNF-a and NF-?B signaling play a critical role in cigarette smoke-induced epithelial-mesenchymal transition of retinal pigment epithelial cells in proliferative vitreoretinopathy. PLoS One. 2022; 17(9):e0271950.

View in: PubMed

People

Explore

Similar Concepts

Top Journals

The Thomas Jefferson University web site, its contents and programs, is provided for informational and educational purposes only and is not intended as medical advice nor is it intended to create any physician-patient relationship. Please remember that this information should not substitute for a visit or a consultation with a health care provider. The views or opinions expressed in the resources provided do not necessarily reflect those of Thomas Jefferson University, Thomas Jefferson University Hospital, or the Jefferson Health System or staff.
Please read our Privacy Statement